person

Antonio R. D.

Country
Spain
Department
Medical Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
126
Sites with multiple studies

Has run more than one trial at 126 of 303 partner sites.

Specializations

Lymphoma Research

The investigator specializes in treating B-cell Non-Hodgkin's Lymphoma (NHL), with particular emphasis on relapsed and refractory cases. Their expertise extends to various NHL subtypes including diffuse large B-cell lymphoma (DLBCL) and transformed follicular lymphoma.

  • Large B-cell lymphoma (LBCL)
  • High-grade B-cell lymphoma (HGBCL)
  • Primary mediastinal large B-cell lymphoma (PMBCL)

Their research encompasses novel therapeutic approaches for patients with resistant forms of lymphoma.

Immunotherapy Focus

The investigator concentrates on innovative immunotherapeutic approaches, particularly studying CD19-targeted therapies and combination immunotherapy regimens. Their work involves evaluating novel antibody treatments and their combinations.

  • Targeted antibody therapy
  • T-cell engagement strategies
  • Immune response monitoring

The research includes assessment of immune cell infiltration and response in lymphoid malignancies.

Treatment Development

Their work involves developing and evaluating novel therapeutic combinations for hematologic malignancies. The investigator studies advanced treatment approaches including molecular imaging techniques to monitor treatment response.

  • Combination therapy optimization
  • Treatment resistance mechanisms
  • Response assessment methodologies

The research incorporates innovative imaging techniques to evaluate treatment effectiveness.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.